New horizons in treatment of osteoporosis

O Tabatabaei-Malazy, P Salari, P Khashayar… - DARU Journal of …, 2017 - Springer
Background Prevalence of osteoporosis is increasing both in developed and developing
countries. Due to rapid growth in the burden and cost of osteoporosis, worldwide, it seems …

Pharmacological therapy of osteoporosis: a systematic current review of literature

V Pavone, G Testa, SMC Giardina, A Vescio… - Frontiers in …, 2017 - frontiersin.org
Osteoporosis is the most common bone disease affecting millions of people worldwide,
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …

Therapeutic treatments for osteoporosis—which combination of Pills is the best among the bad?

CH Tonk, SH Shoushrah, P Babczyk… - International journal of …, 2022 - mdpi.com
Osteoporosis is a chronical, systemic skeletal disorder characterized by an increase in bone
resorption, which leads to reduced bone density. The reduction in bone mineral density and …

[HTML][HTML] Drugs for the management of osteoporosis: a review

DK Khajuria, R Razdan, DR Mahapatra - Revista brasileira de …, 2011 - SciELO Brasil
A osteoporose caracteriza-se por reduzida massa óssea e deterioração microarquitetural do
tecido ósseo, o que aumenta a fragilidade óssea e, portanto, a suscetibilidade a fraturas. A …

Current, new and future treatments of osteoporosis

P Salari Sharif, M Abdollahi, B Larijani - Rheumatology international, 2011 - Springer
Osteoporosis as a common chronic disease is challenging human health. Although different
therapeutic options are routinely used for prevention/treatment of osteoporosis, their side …

Osteoporosis therapies and their mechanisms of action

B Kim, YJ Cho, W Lim - Experimental and therapeutic …, 2021 - spandidos-publications.com
Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …

An overview of the management of osteoporosis in the aging female population

U Amin, A McPartland, M O'Sullivan… - Women's Health, 2023 - journals.sagepub.com
Osteoporosis is a systemic skeletal disease that is a cause of morbidity and mortality. It can
affect all ages but most frequently postmenopausal women. It is a silent condition, however …

Pharmacological therapy of osteoporosis: what's new?

G Iolascon, A Moretti, G Toro, F Gimigliano… - … interventions in aging, 2020 - Taylor & Francis
Osteoporosis and fragility fractures are relevant health issues because of their impact in
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …

[PDF][PDF] Pharmacological agents and natural compounds: available treatments for osteoporosis.

M Martiniakova, M Babikova, R Omelka - Journal of Physiology & …, 2020 - jpp.krakow.pl
Osteoporosis, a systemic skeletal disease characterized by a decrease in bone mass and
deterioration of bone structure leading to an increased risk of fragility fractures, represents …

[PDF][PDF] Osteoporosis-risk factors, pharmaceutical and non-pharmaceutical treatment.

W Tański, J Kosiorowska… - European Review for …, 2021 - researchgate.net
Osteoporosis is a metabolic disease of the skeletal system which currently affects over 200
million patients worldwide. The WHO criteria define osteoporosis as low bone mineral …